ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 157 filers reported holding ASCENDIS PHARMA A/S in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $772,000 | +63.6% | 5,000 | +19.2% | 0.21% | +18.3% |
| Q1 2020 | $472,000 | -32.2% | 4,195 | -16.1% | 0.18% | +63.6% |
| Q4 2019 | $696,000 | -27.7% | 5,000 | -50.0% | 0.11% | -20.1% |
| Q3 2019 | $963,000 | -16.4% | 10,000 | 0.0% | 0.13% | 0.0% |
| Q2 2019 | $1,152,000 | -2.1% | 10,000 | 0.0% | 0.13% | +38.1% |
| Q1 2019 | $1,177,000 | +87.7% | 10,000 | 0.0% | 0.10% | +83.0% |
| Q4 2018 | $627,000 | -11.6% | 10,000 | 0.0% | 0.05% | +17.8% |
| Q3 2018 | $709,000 | +6.6% | 10,000 | 0.0% | 0.04% | +4.7% |
| Q2 2018 | $665,000 | – | 10,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 10,719,555 | $1,003,779,130 | 19.76% |
| Q Global Advisors, LLC | 285,000 | $26,687 | 17.16% |
| Finepoint Capital LP | 163,772 | $15,335,610 | 7.64% |
| Avoro Capital Advisors LLC | 3,670,000 | $343,658,800 | 5.36% |
| Spyglass Capital Management LLC | 614,618 | $57,552,830 | 4.51% |
| Sofinnova Investments, Inc. | 754,032 | $70,607,556 | 4.45% |
| Saturn V Capital Management LP | 112,473 | $10,531,972 | 4.41% |
| DAFNA Capital Management LLC | 136,212 | $12,754,892 | 3.97% |
| ARS Investment Partners, LLC | 285,918 | $26,773,362 | 3.32% |
| Ghost Tree Capital, LLC | 85,000 | $7,959,400 | 2.62% |